Daily Technical Summary Reports on Medical Equipment Stocks -- Hologic, Wright Medical, MiMedx, and Stryker

NEW YORK, September 5, 2017 /PRNewswire/ --

If you want a Stock Review on HOLX, WMGI, MDXG, or SYK then come over to http://dailystocktracker.com/register and sign up for your free customized report. In today's pre-market research, DailyStockTracker.com redirects investors' attention to Hologic Inc. (NASDAQ: HOLX), Wright Medical Group N.V. (NASDAQ: WMGI), MiMedx Group Inc. (NASDAQ: MDXG), and Stryker Corp. (NYSE: SYK). Medical Appliances and Equipment companies engage in the manufacture of medical instruments such as dental and surgical appliances. They also tend to offer below-average dividend yields when compared to the wider market. Register now and get full and free access to these DailyStockTracker.com research reports at:



Marlborough, Massachusetts headquartered Hologic Inc.'s shares recorded a trading volume of 1.77 million shares last Friday. The stock finished the trading session 0.23% lower at $38.51. The Company's shares are trading below their 200-day moving average by 7.76%. Furthermore, shares of Hologic, which develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the US, Europe, the Asia-Pacific, and internationally, have a Relative Strength Index (RSI) of 42.23.

On August 31st, 2017, Hologic announced the US commercial availability of the Brevera (R) breast biopsy system with CorLumina(R) imaging technology, a groundbreaking, real-time, breast biopsy and verification system that enhances workflow, improves the patient experience, and streamlines the entire biopsy process from start to finish. The first-of-its-kind Brevera system is designed to increase biopsy accuracy with real-time imaging that delivers valuable information at the point of care, enabling clinicians to make informed decisions with confidence. Access our complete research report on HOLX for free at:


Wright Medical Group 

On Friday, Amsterdam, the Netherlands headquartered Wright Medical Group N.V.'s stock ended the session 0.57% higher at $29.77. A total volume of 564,456 shares was traded. The Company's shares have gained 7.71% in the last one month, 7.90% over the previous three months, and 29.55% on an YTD basis. The stock is trading 7.76% above its 50-day moving average and 10.20% above its 200-day moving average. Moreover, shares of Wright Medical, which designs, manufactures, markets, and sells extremities and biologics products in the US, Europe, Middle-East, Africa, and internationally, have an RSI of 68.59.

On August 17th, 2017, Wright Medical announced that it will present at the Wells Fargo Healthcare Conference on September 07th, 2017, at the Westin Boston Waterfront Hotel in Boston, Massachusetts. Robert Palmisano, President and CEO, will present at 8:15 a.m. ET. A live audio webcast of the conference presentation, along with the accompanying presentation materials, will be available on the Company's website. The complimentary research report on WMGI can be downloaded at: http://dailystocktracker.com/registration/?symbol=WMGI


Marietta, Georgia headquartered MiMedx Group Inc.'s stock ended the day 1.60% higher at $16.53 with a total trading volume of 1.17 million shares. The Company's shares have gained 12.45% in the last month, 13.45% over the previous three months, and 86.57% on an YTD basis. The stock is trading 7.61% and 42.33% above its 50-day and 200-day moving averages, respectively. Additionally, shares of MiMedx, which develops and markets regenerative biologics utilizing human placental tissue allografts with patent-protected processes for various sectors of healthcare, have an RSI of 57.46.

On August 31st, 2017, MiMedx announced that its latest peer-reviewed clinical study of the Company's dehydrated human amnion/chorion membrane allografts was accepted for publication in the International Wound Journal. The electronic publication of the article is expected to be made in the next few weeks. At that time, the Company expects to issue a follow-up press release with the detailed study results and link to the article. Register for free on DailyStockTracker.com and get access to the latest report on MDXG at:



Shares in Kalamazoo, Michigan headquartered Stryker Corp. recorded a trading volume of 932,343 shares. The stock ended Friday's session 0.20% lower at $141.09. The Company's shares have gained 17.76% since the start of this year. The stock is trading above its 200-day moving average by 7.05%. Furthermore, shares of Stryker, which together with its subsidiaries, operates as a medical technology company, have an RSI of 45.94.

On August 23rd, 2017, Stryker announced that it has informed the US FDA of a voluntary product recall involving specific lots of Oral Care products sold through the Company's Sage Products business unit (Sage). The recalled products contain Oral Care solutions manufactured for Sage by a third-party supplier and were distributed between July 2015 and August 2017.

On August 25th, 2017, research firm Needham upgraded the Company's stock rating from 'Underperform' to 'Hold'. Download your free research report on SYK at:



Daily Stock Tracker: 

Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

DST has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email contact@dailystocktracker.com. Rohit Tuli, a CFA(R) charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit



        For any questions, inquiries, or comments reach out to us directly. If you're a company
         we are covering and wish to no longer feature on our coverage list contact us via
         email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: 
        Email: contact@dailystocktracker.com 
        Phone number: (207)331-3313 
        Office Address: 377 Rivonia Boulevard, Rivonia, South Africa 


CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

SOURCE dailystocktracker.com